微信直播

专访 | Hiroyuki Daiko:一名优秀的胸外科医生要保持对专业的热忱

嘉琪 李
关键词:

编者按:2018年4月20~22日,由中国抗癌协会食管癌专业委员会主办,四川省西部放射治疗协会和电子科技大学医学院附属肿瘤医院(四川省肿瘤医院)承办的第一届东亚食管癌多学科综合治疗学术会议在天府之国成都隆重召开。AME出版社编辑有幸邀请到本次会议特邀讲者,来自日本National Cancer Center Hospital CENTRAL & EAST的Hiroyuki Daiko教授进行专访。Hiroyuki Daiko教授分享了日本食管鳞状细胞癌新辅助治疗的现状,同时也期待未来和中国展开食管癌领域的合作,最后给年轻胸外科医生送上了一些寄语。

图1. Hiroyuki Daiko教授

人物聚焦

Hiroyuki Daiko

Director of Esophageal Surgical Division, Department of Gastrointestinal Oncology 
National Cancer Center Hospital CENTRAL & EAST, Japan.

He is a member of Japan Esophageal Society, Japan Society For Endoscopic Surgery, Japanese Society of Gastroenterology, Japan Surgical Society. He Has conducted 1 JCOG clinical trial as principal investigator (PI) and 2 JCOG clinical trials as sub-principal investigator for cancer of esophagus.      

点击观看采访视频!~

采访问题

1. As a distinguished invited speaker for this conference, would you like to summarize some main points of your speech to share with us?

2. Are there any challenges in neoadjuvant therapy for Esophageal  Squamous Cell Carcinoma?

3. We’ve learned that you are a member of Japan Esophageal Society. Do you have any plans for further cooperation with China in the field of esophagus cancer?

4. Could you give some suggestions for younger generation to be excellent surgeons?

推荐阅读

采写:李嘉琪,AME Publishing Company

摄像:李鹏程,AME Publishing Company

责任编辑:李亮,AME Publishing Company

视频剪辑:麦雪芳,AME Publishing Company

排版编辑:许梦杨,AME Publishing Company

comments powered by Disqus

附件